4.7 Article

Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 274, Issue -, Pages 298-304

Publisher

ELSEVIER
DOI: 10.1016/j.jad.2020.05.132

Keywords

Cannabis; PTSD; Intrusions; Flashbacks; Anxiety; Irritability

Funding

  1. Washington State University's Drug and Alcohol Research Program

Ask authors/readers for more resources

Background: Many individuals use cannabis to manage symptoms of post-traumatic stress disorder (PTSD), and evidence indicates that the endocannabinoid system represents a viable target for treating these symptoms. Method: Data from 404 medical cannabis users who self-identified as having PTSD were obtained from Strainprint (R), a medical cannabis app that patients use to track changes in symptoms as a function of different strains and doses of cannabis across time. This sample collectively used the app 11,797 times over 31 months to track PTSD-related symptoms (intrusive thoughts, flashbacks, irritability, and/or anxiety) immediately before and after inhaling cannabis. Latent change score models were used to examine changes in symptom severity and predictors of these changes (gender, dose, cannabis constituents, time). Multilevel models were used to explore long-term consequences of repeatedly using cannabis to manage these symptoms. Results: All symptoms were reduced by more than 50% immediately after cannabis use. Time predicted larger decreases in intrusions and irritability, with later cannabis use sessions predicting greater symptom relief than earlier sessions. Higher doses of cannabis predicted larger reductions in intrusions and anxiety, and dose used to treat anxiety increased over time. Baseline severity of all symptoms remained constant across time. Limitations: The sample was self-selected, self-identified as having PTSD, and there was no placebo control group. Conclusions: Cannabis provides temporary relief from PTSD-related symptoms. However, it may not be an effective long-term remedy as baseline symptoms were maintained over time and dose used for anxiety increased over time, which is indicative of development of tolerance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Multidisciplinary

Out, proud, and resilient: effects of sexual identity labels on perceptions of sexual minorities

Kyle A. Schofield, Steven Hobaica, Alexander Jensen, Carrie Cuttler

Summary: Research indicates that openly disclosing one's sexual identity, either explicitly or implicitly, in a liberal university setting, may enhance positive perceptions of LGB individuals by others, particularly in positive traits, with minimal impact on negative traits.

PSYCHOLOGY & SEXUALITY (2022)

Article Psychology, Biological

A Crowdsourcing Survey Study on the Subjective Effects of Delta-8-Tetrahydrocannabinol Relative to Delta-9-Tetrahydrocannabinol and Cannabidiol

Cecilia L. Bergeria, Justin C. Strickland, Tory R. Spindle, Maja Kalaba, Prem Umang Satyavolu, Matthew Feldner, Ryan Vandrey, Marcel Bonn-Miller, Erica N. Peters, Elise Weerts

Summary: Delta-8-tetrahydrocannabinol (Delta 8-THC) is a new retail cannabinoid product in the U.S. This study investigated the characteristics and effects of Delta 8-THC use. Participants reported that Delta 8-THC had weaker effects than Delta 9-THC and stronger effects than CBD. Users cited reasons for Delta 8-THC use including its legal status, similarity to Delta 9-THC, and milder effects. Human laboratory studies are needed to further understand the pharmacokinetics, pharmacodynamics, and cognitive effects of Delta 8-THC.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2023)

Article Psychology, Multidisciplinary

Progressive, but promiscuous and confused: perceptions of sexual minority identity labels in a nationally representative sample

Alexander Jensen, Kyle A. Schofield, Amanda Stueber, Steven Hobaica, Carrie Cuttler

Summary: Selecting and sharing a sexual identity label is a significant and stressful process for LGB individuals. Previous research has shown that using sexual identity labels tends to have positive effects in liberal-leaning environments, but may lead to more negative perceptions in the general population.

PSYCHOLOGY & SEXUALITY (2023)

Letter Medical Laboratory Technology

Likelihood of Positive Urine Screens of THC-COOH After Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used

Morgan L. Ferretti, Ryan Vandrey, Jessica G. Irons, Heather Jackson, Mallory J. Loflin, Travis Hyke, Marcel O. Bonn-Miller

THERAPEUTIC DRUG MONITORING (2023)

Article Pharmacology & Pharmacy

Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults

Laura MacNair, Justyna Kulpa, Melanie L. Hill, Graham M. L. Eglit, Irina Mosesova, Marcel O. Bonn-Miller, Erica N. Peters

Summary: There is a lack of data on sex differences in the pharmacokinetics of CBD and its primary metabolites. This study analyzed data from a multiple-dose trial of a CBD-dominant oral cannabis product and found that females exhibited greater exposure to CBD metabolites in plasma over time, indicating potential sex differences in CBD metabolism or elimination.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Substance Abuse

Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis

Joshua A. Lile, Brian W. Turner, David H. Cox, Marcel O. Bonn-Miller, Ned R. Katz, Thomas P. Shellenberg, William W. Stoops, Justin C. Strickland

Summary: This study explores the preferences of individuals interested in treating cannabis use disorder (CUD). The results suggest that CUD medications should be nonsynthetic compounds administered orally or by mouth spray once per day, and remote adherence monitoring and one-on-one outpatient behavioral treatments, particularly contingency management, are anticipated to enhance participation. Most participants prefer to reduce, rather than quit, their cannabis use.

JOURNAL OF ADDICTION MEDICINE (2023)

Article Pharmacology & Pharmacy

Pot at the End of the Rainbow: Cannabis Use Among Sexual Minorities

Kyle Schofield, Carrie Cuttler, Bradley T. Conner, Mark A. Prince

Summary: Gay, lesbian, and bisexual individuals have a higher frequency of cannabis use compared to heterosexuals, but there is limited research on the patterns of cannabis use and motivations among sexual minorities. This study found that bisexual individuals were more likely to use cannabis, use it more frequently, use various forms of cannabis, and experience more severe symptoms of cannabis use disorder. They also reported higher levels of mental health symptoms compared to heterosexuals.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats

Bryan W. Jenkins, Catherine F. Moore, Dan Covey, Jacob D. McDonald, Timothy W. Lefever, Marcel O. Bonn-Miller, Elise M. Weerts

Summary: This study evaluated the effects of minor cannabinoids and terpenes in tests sensitive to anxiety. The results suggest that some minor cannabinoids and terpenes may have anxiolytic properties.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Toxicological Evaluation and Pain Assessment of Four Minor Cannabinoids Following 14-Day Oral Administration in Rats

Justyna Kulpa, Rayetta G. Henderson, Daniela Schwotzer, Wendy Dye, Kristen R. Trexler, Jacob Mcdonald, Timothy W. Lefever, Marcel O. Bonn-Miller

Summary: Minor cannabinoids were well tolerated at the assessed doses during 14 days of daily oral administration. Modest, dose-dependent trends in relative organ weights and serum chemistry parameters warrant further study at higher oral doses.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Oral Cannabidiol Treatment in Two Postmenopausal Women with Osteopenia: A Case Series

Justyna Kulpa, Amy Harrison, Lance Rudolph, Graham M. L. Eglit, Cynthia Turcotte, Marcel O. Bonn-Miller, Erica N. Peters

Summary: This case series explores the effects of oral CBD administration on bone turnover in postmenopausal women. The study found that CBD was well tolerated and associated with a reduction in measured markers of bone turnover. Large-scale randomized clinical trials are needed to further investigate the bone protective effects of CBD in postmenopausal women.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Evaluation of the Modulatory Effects of Minor Cannabinoids and Terpenes on Delta-9-Tetrahydrocannabinol Discrimination in Rats

Catherine F. Moore, Julie Marusich, Mehdi Haghdoost, Timothy W. Lefever, Marcel O. Bonn-Miller, Elise M. Weerts

Summary: This study found that the minor cannabinoids and terpenes in cannabis have little effect on the interoceptive effects of D9-THC, suggesting that they are unlikely to lower the psychoactive effects of D9-THC in human users.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain

Catherine F. Moore, Elise M. Weerts, Justyna Kulpa, Daniela Schwotzer, Wendy Dye, Jacob Jantzi, Jacob D. McDonald, Timothy W. Lefever, Marcel O. Bonn-Miller

Summary: This study examined the pharmacokinetics of four minor cannabinoids (THCV, CBC, CBN, and D8-THC) after repeated oral dosing. The results showed detectable levels of these cannabinoids in plasma and their translocation to brain tissue. D8-THC exhibited the highest dose-normalized Cmax and AUClast. The concentration of THCV was lower on day 14, indicating potential adaptation and increased drug elimination. These findings are important for determining target dose ranges and dosing schedules in future studies evaluating the potential effects of these compounds.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder

Marcel O. Bonn-Miller, Megan Brunstetter, Alex Simonian, Mallory J. Loflin, Ryan Vandrey, Kimberly A. Babson, Hal Wortzel

Summary: This study found that PTSD patients who used cannabis experienced a greater decrease in symptom severity and were more likely to no longer meet the diagnostic criteria for PTSD. It suggests that medical cannabis could serve as an alternative treatment for PTSD.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain

Carrie Cuttler, Emily M. LaFrance, Rebecca M. Craft

Summary: Inhaled cannabis reduces self-reported pain severity by approximately 42-49%, but these reductions appear to diminish over time and patients may require larger doses for pain relief. Factors such as gender, method of administration, and dose have an impact on the reduction of pain. The study suggests the development of analgesic tolerance with continued use.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

In VitroScreening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function

Lyndsey L. Anderson, Maia G. Etchart, Laura MacNair, M. Hunter Land, Irina A. Mosesova, Marcel O. Bonn-Miller, Jonathon C. Arnold

Summary: The legalization of medicinal cannabis has led to increased use of commercial cannabis-based products, which can potentially interact with other drugs. This study evaluated the inhibitory potential of three commercially available cannabis-based products on human transporters and found that some of these products can inhibit transporter function.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Clinical Neurology

Characterizing depression after traumatic brain injury using a symptom-oriented approach

Jai Carmichael, Jennie Ponsford, Kate Rachel Gould, Gershon Spitz

Summary: The traditional approaches to measuring depression after traumatic brain injury (TBI) have limitations. This study adopted a symptom-oriented approach and found that post-TBI depression is highly heterogeneous. Different depressive symptoms have distinct associations with personal, injury-related, treatment, and outcome factors.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

Response to Słupski & Słupska

Josine E. Verhoeven, Laura K. M. Han, Brenda W. J. H. Penninx

JOURNAL OF AFFECTIVE DISORDERS (2024)

Review Clinical Neurology

The association between trichotillomania symptoms and emotion regulation difficulties: A systematic review and meta-analysis

Erin Crowe, Petra K. Staiger, Steven J. Bowe, Imogen Rehm, Richard Moulding, Caitlyn Herrick, David J. Hallford

Summary: This study aimed to integrate the evidence regarding the relationship between emotion regulation difficulties and TTM symptoms, and found that individuals with higher levels of TTM severity appear to exhibit decreased overall emotion regulation abilities and strategies.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

'The association between gut-health promoting diet and depression: A mediation analysis'

Fjolla Berisha, Marjolaine Rivest-Beauregard, Jai Shah, Michelle Lonergan, Alain Brunet

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The impact of sleep disturbances on suicide risk among people living HIV: An eleven-year national cohort

Yi-Tseng Tsai, Tzu-Jung Chuang, Sriyani Padmalatha Konara Mudiyanselage, Han-Chang Ku, Yi-Lin Wu, Chung-Yi Li, Nai-Ying Ko

Summary: Sleep disturbances are associated with higher suicide rates, and this association is independent of depression. Paying attention to sleep disturbances among PLHIV is crucial when monitoring suicidal ideation.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Patterns in suicide by marital status in Hong Kong, 2002-2020: Is marriage still a protective factor against suicide?

Junyou Chen, Ingrid D. Lui, Yu Cheng Hsu, Paul S. F. Yip

Summary: Despite rapid social changes in Hong Kong, marriage remains a strong protective factor against suicide for both men and women, particularly among younger individuals. Increasing suicide rates among divorced/separated, never-married, or widowed individuals suggest a need for more psychosocial support.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Perinatal sleep disruption and postpartum psychosis in bipolar disorder: Findings from the UK BDRN Pregnancy Study

A. Perry, K. Gordon-Smith, K. J. S. Lewis, A. Di Florio, N. Craddock, L. Jones, I. Jones

Summary: This study found that the experience of losing at least one night of sleep was associated with an increased risk of postpartum psychosis in women with bipolar disorder. Sleep quality in late pregnancy was not associated with postpartum psychosis, and perinatal sleep disruption was not associated with postpartum depression.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Dear J. Affect Disord, Mark J. Niciu, Robert C. Meisner, Brent R. Carr, Ali A. Farooqui, David Feifel, Adam Kaplin, Paul M. Kim, Christopher D. Schneck, Jennifer L. Vande Voort, Sagar Parikh, E. Jeremy Kendrick

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The relationship between psychological pain and suicidality in patients with major depressive disorder: A meta-analysis

Tao Wang, Li Yang, Lan Yang, Bao-Peng Liu, Cun-Xian Jia

Summary: This study systematically reviewed the association between psychological pain and suicidality in patients with major depressive disorder (MDD). The results showed that psychological pain was a risk factor for suicidality in MDD patients, especially for those of advancing age. Reducing psychological pain in MDD patients is important for preventing suicidality.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

Spilling the tea about milk tea addiction - A reply to Qu et al. (2023)

Juan Carlos Hugues, Abel Nogueira-Lopeza, Maeva Flayellea, Cora von Hammersteind, Joel Billieuxa

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The role of family accommodation in child posttraumatic stress symptoms and functional impairment in the context of cognitive behavioral therapy

Ogechi Cynthia Onyeka, Samuel D. Spencer, Alison Salloum, Katie Jiannetto, Eric A. Storch

Summary: This study examined the relationship among family accommodation (FA), posttraumatic stress symptoms (PTSS), and functional impairment. The results showed that FA was significantly associated with PTSS and functional impairment. Baseline FA partially mediated the relationship between baseline PTSS and functional impairment. Changes in FA from pre- to post-treatment were associated with relevant outcome variables at post-treatment and 12-month follow-up.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Effect of dietary living microbe intake on depression symptom in American adult: An opinion from NHANES study

Yumeng Shi, Chao Yu

Summary: This study found a negative correlation between the intake of active microbes in the diet and depression.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Analysis of sleep for the American population: Result from NHANES database

Qiurui Nie, Yu Shen, Mengqin Luo, Zhiyong Sheng, Rui Zhou, Guangmin Li, Wei Huang, Shenjian Chen

Summary: The study assessed the sleep duration, sleep disorders, and trouble sleeping among adults in the United States from 2005 to 2018, revealing a high prevalence of abnormal sleep durations and increasing rates of sleep disorders and trouble sleeping.

JOURNAL OF AFFECTIVE DISORDERS (2024)